Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk reduction.

There's now a prescription GLP-1 pill for weight loss on the market. Here are six key things to know about it.

Whether you're answering emails, surfing the web, or just gaming on the go, we've got a tablet that can do it all at a low price this month. I’m PCMag’s managing editor for consumer electronics ...

The FDA has approved Myqorzo (aficamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).

Cytokinetics has announced that the US Food and Drug Administration (FDA) has approved MYQORZO (aficamten) tablets in 5mg, ...

In one study, Ozempic users lost almost 6 percent of their body weight after three months. According to preliminary data from ...

The US Food and Drug Administration (FDA) has approved a pill version of the weight-loss drug Wegovy, according to pharmaceutical giant Novo Nordisk. It is the first pill of its kind to receive ...

Experts in Indigenous cancer health at Roswell Park discuss the need to overcome the healthcare disparities and cultural barriers faced by Native Americans. Many Paths, One Purpose: Cancer and Other ...

The criteria for consideration of translational and clinical research in Nature Medicine are originality, timeliness and impact on improving human health by addressing unmet clinical needs. Original ...